The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3.

Biochem J

Department of Systems Research, GlaxoSmithKline Research and Development, Gunnels Wood Road, Stevenage SG1 2NY, U.K.

Published: January 2003

The integrins alpha(v)beta(1), alpha(v)beta(5), alpha(v)beta(6) and alpha(v)beta(8) have all recently been shown to interact with the RGD motif of the latency-associated peptide (LAPbeta(1)) of transforming growth factor beta(1) (TGFbeta(1)), with binding to alpha(v)beta(6) and alpha(v)beta(8) leading to TGFbeta(1) activation. Previously it has been suggested that the remaining alpha(v) integrin, alpha(v)beta(3,) does not interact with LAPbeta(1). However, here we show clearly that alpha(v)beta(3) does indeed interact with the LAPbeta(1) RGD motif. This interaction is similar to other alpha(v)beta(3) ligands in terms of the cations required for adhesion, the concentrations of LAPbeta(1) required for binding and the ability of a small-molecule inhibitor of alpha(v)beta(3), SB223245, to block the interaction. Using glutathione S-transferase fusion proteins we have mapped a minimal integrin-binding loop in LAPbeta(1) and then used this approach to probe the integrin-binding properties of the equivalent loops in LAPbeta(2) and LAPbeta(3). We show that the RGD motif of LAPbeta(3) also interacts with alpha(v)beta(3), in addition to alpha(v)beta(6), alpha(v)beta(1) and alpha(v)beta(5), whereas the corresponding loop in LAPbeta(2) does not interact with these integrins. These observations therefore correct a previously reported inaccuracy in the literature. Furthermore, they are important as they link alpha(v)beta(3) and TGFbeta, which may have implications in cancer and a number of inflammatory and fibrotic diseases where expression of both proteins has been documented.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1223078PMC
http://dx.doi.org/10.1042/BJ20020809DOI Listing

Publication Analysis

Top Keywords

rgd motif
12
integrin alphavbeta3
8
transforming growth
8
alphavbeta1 alphavbeta5
8
alphavbeta6 alphavbeta8
8
alphavbeta3 interact
8
interact lapbeta1
8
alphavbeta3
6
lapbeta1
5
alphavbeta3 receptor
4

Similar Publications

Facile universal strategy of presenting multifunctional short peptides for customizing desired surfaces.

J Nanobiotechnology

January 2025

Department of Spinal Surgery, The First People's Hospital of Wenling, Affiliated Wenling Hospital, Wenzhou Medical University, Taizhou, Zhejiang, 317500, China.

Article Synopsis
  • Interfacial properties of biomaterials influence critical functions like cell adhesion and tissue repair, making their manipulation essential for clinical applications.
  • The study develops a versatile layer-by-layer (LbL) strategy to effectively attach peptides to substrates using polyphenols, enhancing interfacial functionalities.
  • The resulting peptide-polyphenol coatings demonstrate broad applicability, stability, and the ability to incorporate various functional molecules for improved biomaterial performance.
View Article and Find Full Text PDF

The extracellular matrix (ECM) is a complex meshwork comprising over 100 proteins. It serves as an adhesive substrate for cells and, hence, plays critical roles in health and disease. We have recently identified a novel ECM protein, SNED1, and have found that it is required for neural crest cell migration and craniofacial morphogenesis during development and in breast cancer, where it is necessary for the metastatic dissemination of tumor cells.

View Article and Find Full Text PDF

Amphiphilic self-assembling peptides: formulation and elucidation of functional nanostructures for imaging and smart drug delivery.

Anal Bioanal Chem

December 2024

Institute of Chemistry for Life & Health Sciences (iCLeHS), Chimie ParisTech, PSL University, CNRS 8060, 75005, Paris, France.

The rational design of self-assembled peptide-based nanostructures for theranostics applications requires in-depth physicochemical characterization of the peptide nanostructures, to understand the mechanism and the interactions involved in the self-assembly, allowing a better control of the objects' physicochemical and functional properties for theranostic applications. In this work, several complementary characterization methods, such as dynamic light scattering, transmission electron microscopy, circular dichroism, Taylor dispersion analysis, and capillary electrophoresis, were used to study and optimize the self-assembly of pH-sensitive short synthetic amphiphilic peptides containing an RGD motif for active targeting of tumor cells and smart drug delivery. The combined methods evidenced the spontaneous formation of nanorods (L = 50 nm, d = 10 nm) at pH 11, stabilized by β-sheets.

View Article and Find Full Text PDF

For the development of highly multifunctionalized nanomaterials, the introduction of functional molecules on gold nanoclusters containing thiols preinstalled with connecting groupsconstitutes a promising approach. However, the uniform introduction of multiple connecting groups while avoiding side reactions is a challenging task. Herein, the synthesis of gold nanoclusters (ca.

View Article and Find Full Text PDF

Mictlan-D3: A novel medium sized RGD-Disintegrin obtained from Crotalus mictlantecuhtli venom, in vitro tested against human breast Cancer and endothelial cells.

Toxicol In Vitro

December 2024

Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico. Electronic address:

Article Synopsis
  • Disintegrins are non-toxic proteins found in viper snake venom, known for blocking integrin receptors, which are important for cell adhesion and interactions in cancer progression.
  • The study focused on isolating and characterizing a specific disintegrin called mictlan-D3 from the venom of a newly identified rattlesnake species, Crotalus mictlantecuhtli, which consists of two isoforms.
  • Mictlan-D3 showed significant inhibition of cancer cell adhesion and migration, particularly reducing the adhesion of MDA-MB-231 cancer cells to extracellular matrix proteins by up to 81% and their migration by 80%.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!